*Data updated daily at 18:00 EAT
UM6P Ventures, an early-stage venture capital firm, has announced its investment in Infiuss Health to improve clinical trial participation and health equity in Africa. The funding will be used by the startup for its growth plan particularly for developing a decentralized SaaS platform to power remote research and clinical trials in Africa.
Infiuss Health provides clinical trial access to African participants and allows pharmaceutical companies to conduct and monitor these trials via the Infiuss Health Probe Platform. Through a single dashboard, the all-in-one software platform helps companies identify and select suitable sites for trials, manage the entire research process, and recruit participants remotely.